openPR Logo
Press release

Natural Killer Cells Therapeutics Market Analysis Focusing on Top Key Players -Affimed GmbH, Celgene Corporation, Fate Therapeutics, Fortress Biotech, Inc., Glycostem Therapeutics B.V

04-09-2021 04:27 PM CET | Health & Medicine

Press release from: The Insight Partners

Natural Killer Cells Therapeutics

Natural Killer Cells Therapeutics

An exclusive Natural Killer Cells Therapeutics Market research report has been fabricated through the in depth analysis of the market dynamics across five regions including North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation of the market by components, end users, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts (key opinion leaders of companies, and stakeholders) and secondary research (global/regional associations, trade journals, technical white papers, company’s website, annual report SEC filing, and paid databases). Further, the market has been estimated by utilizing various research methodologies and internal statistical model. Natural killer cells lead to immune surveillance against cancer and elimination of small tumor. NK cells are unique, they have the ability to recognize stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction.

Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPRE00008500/?Source=openpr/10392

The research dives deep into the global share, size, and trends, as well as growth rate of the Natural Killer Cells Therapeutics market to project its progress during the forecast period, i.e., 2020–2027. Most importantly, the report further identifies the past, present, and future trends that are expected to influence Natural Killer Cells Therapeutics the development rate of the Natural Killer Cells Therapeutics market. The research segments the market on the basis of product type, application, and region. The natural killer cells therapeutics market is anticipated to rise in the adoption of NK cells for the treatment of cancer, infections, and liver diseases are driving the growth of the natural killer cells therapeutics market. However, higher costs associated with the therapies is restraining market growth. Furthermore, NK cells play a pivotal role in tumor immune-surveillance, which drives market growth.

MARKET SCOPE

The "Natural Killer Cells Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in natural killer cells therapeutics market with detailed market segmentation by therapeutics, application, end user and geography. The natural killer cells therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in natural killer cells therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The natural killer cells therapeutics market is segmented on the basis of therapeutics, application and end user. Based on therapeutics the market is segmented as NK Cell therapies and NK cell directed antibodies. On the basis of application the market is categorized as cancer, gastrointestinal diseases, immunoproliferative disorders and others. On the basis of end user the market is categorized as research centers & institutes, hospitals and others.

Natural Killer Cells Therapeutics Market Key Player Analysis By

- Affimed GmbH

- Celgene Corporation

- Fate Therapeutics

- Fortress Biotech, Inc.

- Glycostem Therapeutics B.V.

- Innate Pharma S.A.

- Nantkwest Inc.

- Nkarta Therapeutics, Inc.

- NKT Therapeutics Inc.,

- Ziopharm Oncology Inc.

A detailed scrutiny of the regional terrain of the Natural Killer Cells Therapeutics market:

– The study broadly exemplifies, the regional hierarchy of this market, while categorizing the same into United States, China, Europe, Japan, Southeast Asia & India.

– The research report documents data concerning the market share held by each nation, along with potential growth prospects based on the geographical analysis.

– The study anticipates the growth rate which each regional segment would cover over the estimated timeframe.

Here we have listed the top Natural Killer Cells Therapeutics Market companies in the world

Reasons for buying this report:

– It offers an analysis of changing competitive scenario.

– For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.

– It offers a seven-year assessment of Natural Killer Cells Therapeutics Market.

– It helps in understanding the major key product segments.

– Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.

– It offers a regional analysis of Natural Killer Cells Therapeutics Market along with business profiles of several stakeholders.

Chapter Details of Natural Killer Cells Therapeutics Market:

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Natural Killer Cells Therapeutics Market Landscape

Part 04: Natural Killer Cells Therapeutics Market Sizing

Part 05: Natural Killer Cells Therapeutics Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00008500/?Source=openpr/10392

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Natural Killer Cells Therapeutics Market Analysis Focusing on Top Key Players -Affimed GmbH, Celgene Corporation, Fate Therapeutics, Fortress Biotech, Inc., Glycostem Therapeutics B.V here

News-ID: 2268408 • Views:

More Releases from The Insight Partners

GNSS Chips and Modules Market to Reach US$ 12.44 Billion by 2031, Driven by 5G Expansion, Wearable Tech, and Smart Infrastructure Growth
GNSS Chips and Modules Market to Reach US$ 12.44 Billion by 2031, Driven by 5G E …
New York, US - November 07, 2025 - According to the latest market research report by The Insight Partners, the Global GNSS (Global Navigation Satellite System) Chips and Modules Market size is expected to grow from US$ 7.20 billion in 2024 to US$ 12.44 billion by 2031, registering a robust CAGR of 8.4% during 2025-2031. The market growth is primarily fueled by the rising demand for 5G connectivity, high-speed internet,
CNC Machine Market Growth Drivers, Market Size, Share, Trends, SWOT Analysis, Future Outlook
CNC Machine Market Growth Drivers, Market Size, Share, Trends, SWOT Analysis, Fu …
The CNC Machine Market is experiencing robust growth, driven by increasing demand for precision manufacturing, automation, and smart technologies. According to The Insight Partners' report, the market is projected to grow at a CAGR of 5.6% from 2025 to 2031, with expansion across key segments such as lathe machines, milling machines, laser machines, grinding machines, welding machines, and others. Major end-user industries include aerospace and defense, automotive, industrial, metals and
Extracorporeal CO2 Removal Devices Market Set for Steady Growth Driven by Advances in Critical Care Technology
Extracorporeal CO2 Removal Devices Market Set for Steady Growth Driven by Advanc …
United States of America - November 7, 2025 - The Insight Partners has unveiled its latest research report titled "Extracorporeal CO2 Removal Devices Market: An In-depth Analysis of the Global Market." The study offers a comprehensive evaluation of current market dynamics, key drivers, emerging trends, and future opportunities shaping the Extracorporeal CO2 Removal Devices Market from 2025 to 2031. The extracorporeal CO2 removal devices market is projected to reach US$182.88
Upper Limb Prosthesis Market to Register a CAGR of 5.9% from 2025 to 2031
Upper Limb Prosthesis Market to Register a CAGR of 5.9% from 2025 to 2031
The Upper Limb Prosthesis Market is expected to register a CAGR of 5.9% from 2025 to 2031, driven by rapid advancements in biomechanical engineering, robotics, and material sciences. The market continues to expand as the demand for technologically advanced prosthetic solutions grows among amputees, healthcare institutions, and rehabilitation centers worldwide. Check valuable insights in the Upper Limb Prosthesis Market report. You can easily get a sample PDF of the report -

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant